Clinical Trial Update: A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ORP-101 to placebo in adults with irritable bowel syndrome with diarrhea (IBS-D) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• ORP-101

Snippet

Sponsor: OrphoMed, Inc. | Conditions: Irritable Bowel Syndrome With Diarrhea | Phase 2 | Status: COMPLETED